[{"from": "human", "value": "Describe this molecule. [C][C][/C][=Branch2][Ring1][P][=C][Branch1][N][\\C][=C][C][=C][Branch1][Branch1][C][=C][Ring1][=Branch1][O][/C][=C][C][=C][Branch1][Branch1][C][=C][Ring1][=Branch1][O][C][C][N][Branch1][C][C][C][/C][=C][C][=C][C][=C][Ring1][=Branch1]"}, {"from": "gpt", "value": "The molecule is a new estrogen inhibitor under investigation for a variety of estrogen-dependent conditions, including cyclic breast pain and gynecomastia. TamoGel is formulated using Enhanced Hydroalcoholic Gel (EHG) Technology. This technology enables percutaneous delivery of drugs that cannot be delivered orally. It is being developed by Ascent Therapeutics."}]